194 results on '"Eberhardt, Christiane S"'
Search Results
2. Contributors
3. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
4. Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
5. A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project
6. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
7. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms
8. Defining HPV-specific B cell responses in patients with head and neck cancer
9. Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
10. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
11. Immune escape of Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, XBB.1.5, EG.5.1 and JN.1.1 after vaccination, infection and hybrid immunity
12. Mise à jour des vaccins chez les personnes âgées
13. Understanding the immunology of the Zostavax shingles vaccine
14. Paediatric acute respiratory distress syndrome
15. Cautious Interpretation of Optimal Timing of Maternal Pertussis Immunization
16. Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization
17. Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study
18. Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates
19. Reply to Abu Raya et al
20. Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis
21. Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19
22. T Cell Receptor Repertoire Profiling Reveals Breadth of Cellular Responses Against Sars-Cov-2 after Natural Infection and Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients
23. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
24. Chapter 2 - Vaccine Immunology
25. Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis
26. Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
27. Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
28. Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab
29. Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients
30. Gynécologie-obstétrique. Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021
31. Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
32. Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
33. Omicron-specific cytotoxic T-cell responses are boosted following a third dose of mRNA COVID-19 vaccine in anti-CD20-treated multiple sclerosis patients
34. Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy
35. Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study
36. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
37. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity
38. Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence.
39. SARS‐CoV‐2 infection as a trigger of humoral response against apolipoprotein A‐1
40. Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients
41. Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccines
42. Coronavirus disease 2019 vaccination in transplant recipients
43. Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection
44. Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study.
45. The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer
46. Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association With Viral Load, Independent of Symptoms
47. SARS-CoV2- infection as a trigger of humoral response against apolipoprotein A-1
48. Faudra-t-il vacciner les enfants contre le Covid-19 ?
49. Cholestasis as the leading sign of a transmesenteric hernia in a split-liver transplanted child – A case report and review of literature
50. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.